“Therapeutic Obstructive Sleep Apnea Devices Market by Type (Airway clearance systems, Adaptive servo-ventilation (ASV), Positive airway pressure (PAP) device, Oral appliances, Oxygen Devices, and Others), By End-use (Hospitals & Sleep Laboratories, Home Care Settings), Regional Outlook (Asia-Pacific, North America, LEMEA, Europe), Global Opportunity Analysis and Industry Forecast, 2019–2026.
- RES4072034
- 110 Pages
- January 2020
- Healthcare
Sleep apnea occurs during sleep when the tongue folds with a soft palate which prevents the breath from going through the back of the throat. Therapeutic obstructive sleep apnea may impact people of any age but it is often seen in elderly people above the age of 40, particularly those who are overweight or obese.
Chocking, Non-refreshing sleep, snoring, are some of the common symptoms that are found in the obstructive sleep apnea.
Therapeutic obstructive sleep apnea device market drivers:
As the undiagnosed patients are increasing so it is considered to be one of the most important factors for the sleep apnea devices market. As per the survey conducted by the American Academy of Sleep Medicine (AASM), it is been projected than more than 80% of individuals remain undiagnosed who are suffering from obstructive sleep apnea. If sleep apnea remains untreated for a longer time, then there are high chances that the patient can further face some serious health issues such as diabetes, obesity, high blood pressure and sometimes it may even cause death. Growing awareness among patients can lead to the growth of the obstructive sleep apnea therapy device market. Additionally, the government initiatives to increase awareness among the people about sleep apnea and the advancements in technology are expected to boost the overall sleep apnea devices market size.
Therapeutic obstructive sleep apnea device market restraints:
The main reason for opposing the adoption of the mask is majorly due to the lack of tolerance by the individual, which is mainly due to frustration and fear. The mouth and nose are completely covered by a mask which makes the patient abhorrent to the device which is considered to be the major restraints for the market growth. The cost of therapeutic obstructive sleep apnea devices is very high as compared to the other sleep apnea devices. The fear and the cost are the two main constraints for the increase of the market.
Therapeutic obstructive sleep apnea device market, by Type:
Depending upon the type the Sleep Apnea Devices Market is been segmented into 6 types Oxygen devices, Oral appliances, Adaptive servo-ventilation (ASV), Airway clearance systems, Positive airway pressure (PAP) and others. The positive airway pressure segment held the largest market size in 2018 accounting for $2,187.8 million and is expected to reach $4,542.3 million by 2026, at a CAGR of 9.7% in the forecast period. The device is added to the patient through the nose or the mask is placed on the face at the time of sleep, which gives the user a positive pressure. Positive airways decrease the incidence of sleep apnea and prevent the airways from closing down.
Therapeutic obstructive sleep apnea device market, by End-use
The rising number of hospitals and growing investment in health care the segment for hospitals and sleep laboratories are rising for the obstructive sleep apnea market by generating $2,569.3 million in 2018 and is expected to rise at a CAGR of 9.4% in the forecast period.
Therapeutic obstructive sleep apnea devices market, by Region
North America holds the largest market share for the sleep apnea diagnostics and therapeutics market. North America region registered a large number of cases with sleep apnea and the geriatric population is expected to drive the market with 10.2% CAGR by generating a revenue of $3,970.7 million by 2026. Asia-Pacific is the fastest-growing region for sleep apnea devices since most of the Asian countries have not yet invested in medical facilities and lack of awareness is expected to provide new growth ventures over the forecast period. Asia-Pacific therapeutic obstructive sleep apnea devices market is expected to increase at a CAGR of 9.0% by generating a revenue of $1,777.7 million by 2026.
Key participants in Global Therapeutic obstructive sleep apnea devices:
The major key players in the therapeutic obstructive sleep apnea devices market are Invacare Corporation GE Healthcare, Compumedics Limited, BMC Medical Co., Fisher & Paykel Healthcare, Cadwell Laboratories Inc., Ltd, Braebon Medical Corporation, Becton Dickinson (CareFusion Corporation), Curative Medical Inc., ImThera Medical, Inc.
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.4.1. Assumptions
1.4.2. Forecast parameters
1.5. Data sources
1.5.1. Primary
1.5.2. Secondary
2. Executive Summary
2.1. 360° summary
2.2. Type trends
2.3. End-use trends
3. Market overview
3.1. Market segmentation & definitions
3.2. Key takeaways
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Pricing overview
3.8.1. By type
3.8.2. By end-use
3.8.3. By region
3.9. Market value chain analysis
3.9.1. Stress point analysis
3.9.2. Raw material analysis
3.9.3. Manufacturing process
3.9.4. Distribution channel analysis
3.9.5. Operating vendors
3.9.5.1. Raw material suppliers
3.9.5.2. Product manufacturers
3.9.5.3. Product distributors
3.10. Strategic overview
4. Therapeutic Obstructive Sleep Apnea Devices Market, by Type
4.1. Airway clearance systems
4.1.1. Market size and forecast, by region, 2017-2028
4.1.2. Comparative market share analysis, 2018 & 2028
4.2. Adaptive servo-ventilation (ASV)
4.2.1. Market size and forecast, by region, 2017-2028
4.2.2. Comparative market share analysis, 2018 & 2028
4.3. Positive airway pressure
4.3.1. Market size and forecast, by region, 2017-2028
4.3.2. Comparative market share analysis, 2018 & 2028
4.4. Oral appliances
4.4.1. Market size and forecast, by region, 2017-2028
4.4.2. Comparative market share analysis, 2018 & 2028
4.5. Oxygen devices
4.5.1. Market size and forecast, by region, 2017-2028
4.5.2. Comparative market share analysis, 2018 & 2028
4.6. Others
4.6.1. Market size and forecast, by region, 2017-2028
4.6.2. Comparative market share analysis, 2018 & 2028
5. Therapeutic Obstructive Sleep Apnea Devices Market, by End-use
5.1. Hospitals & Sleep Laboratories
5.1.1. Market size and forecast, by region, 2017-2028
5.1.2. Comparative market share analysis, 2018 & 2028
5.2. Home Care Settings
5.2.1. Market size and forecast, by region, 2017-2028
5.2.2. Comparative market share analysis, 2018 & 2028
6. Therapeutic Obstructive Sleep Apnea Devices Market, by Region
6.1. North America
6.1.1. Market size and forecast, by type, 2016-2026
6.1.2. Market size and forecast, by end-use, 2016-2026
6.1.3. Market size and forecast, by country, 2016-2026
6.1.4. Comparative market share analysis, 2018 & 2026
6.1.5. U.S.
6.1.5.1. Market size and forecast, by type, 2016-2026
6.1.5.2. Market size and forecast, by end-use, 2016-2026
6.1.5.3. Comparative market share analysis, 2018 & 2026
6.1.6. Canada
6.1.6.1. Market size and forecast, by type, 2016-2026
6.1.6.2. Market size and forecast, by end-use, 2016-2026
6.1.6.3. Comparative market share analysis, 2018 & 2026
6.2. Europe
6.2.1. Market size and forecast, by type, 2016-2026
6.2.2. Market size and forecast, by end-use, 2016-2026
6.2.3. Market size and forecast, by country, 2016-2026
6.2.4. Comparative market share analysis, 2018 & 2026
6.2.5. Germany
6.2.5.1. Market size and forecast, by type, 2016-2026
6.2.5.2. Market size and forecast, by end-use, 2016-2026
6.2.5.3. Comparative market share analysis, 2018 & 2026
6.2.6. France
6.2.6.1. Market size and forecast, by type, 2016-2026
6.2.6.2. Market size and forecast, by end-use, 2016-2026
6.2.6.3. Comparative market share analysis, 2018 & 2026
6.2.7. U.K.
6.2.7.1. Market size and forecast, by type, 2016-2026
6.2.7.2. Market size and forecast, by end-use, 2016-2026
6.2.7.3. Comparative market share analysis, 2018 & 2026
6.2.8. Italy
6.2.8.1. Market size and forecast, by type, 2016-2026
6.2.8.2. Market size and forecast, by end-use, 2016-2026
6.2.8.3. Comparative market share analysis, 2018 & 2026
6.2.9. Spain
6.2.9.1. Market size and forecast, by type, 2016-2026
6.2.9.2. Market size and forecast, by end-use, 2016-2026
6.2.9.3. Comparative market share analysis, 2018 & 2026
6.2.10. Russia
6.2.10.1. Market size and forecast, by type, 2016-2026
6.2.10.2. Market size and forecast, by end-use, 2016-2026
6.2.10.3. Comparative market share analysis, 2018 & 2026
6.2.11. Rest of Europe
6.2.11.1. Market size and forecast, by type, 2016-2026
6.2.11.2. Market size and forecast, by end-use, 2016-2026
6.2.11.3. Comparative market share analysis, 2018 & 2026
6.3. Asia-Pacific
6.3.1. Market size and forecast, by type, 2016-2026
6.3.2. Market size and forecast, by end-use, 2016-2026
6.3.3. Market size and forecast, by country, 2016-2026
6.3.4. Comparative market share analysis, 2018 & 2026
6.3.5. China
6.3.5.1. Market size and forecast, by type, 2016-2026
6.3.5.2. Market size and forecast, by end-use, 2016-2026
6.3.5.3. Comparative market share analysis, 2018 & 2026
6.3.6. Japan
6.3.6.1. Market size and forecast, by type, 2016-2026
6.3.6.2. Market size and forecast, by end-use, 2016-2026
6.3.6.3. Comparative market share analysis, 2018 & 2026
6.3.7. India
6.3.7.1. Market size and forecast, by type, 2016-2026
6.3.7.2. Market size and forecast, by end-use, 2016-2026
6.3.7.3. Comparative market share analysis, 2018 & 2026
6.3.8. South Korea
6.3.8.1. Market size and forecast, by type, 2016-2026
6.3.8.2. Market size and forecast, by end-use, 2016-2026
6.3.8.3. Comparative market share analysis, 2018 & 2026
6.3.9. Australia
6.3.9.1. Market size and forecast, by type, 2016-2026
6.3.9.2. Market size and forecast, by end-use, 2016-2026
6.3.9.3. Comparative market share analysis, 2018 & 2026
6.4. LAMEA
6.4.1. Market size and forecast, by type, 2016-2026
6.4.2. Market size and forecast, by end-use, 2016-2026
6.4.3. Market size and forecast, by country, 2016-2026
6.4.4. Comparative market share analysis, 2018 & 2026
6.4.5. Latin America
6.4.5.1. Market size and forecast, by type, 2016-2026
6.4.5.2. Market size and forecast, by end-use, 2016-2026
6.4.5.3. Comparative market share analysis, 2018 & 2026
6.4.6. Middle East
6.4.6.1. Market size and forecast, by type, 2016-2026
6.4.6.2. Market size and forecast, by end-use, 2016-2026
6.4.6.3. Comparative market share analysis, 2018 & 2026
6.4.7. Africa
6.4.7.1. Market size and forecast, by type, 2016-2026
6.4.7.2. Market size and forecast, by end-use, 2016-2026
6.4.7.3. Comparative market share analysis, 2018 & 2026
6.4.8. Saudi Arabia
6.4.8.1. Market size and forecast, by type, 2016-2026
6.4.8.2. Market size and forecast, by end-use, 2016-2026
6.4.8.3. Comparative market share analysis, 2018 & 2026
7. Company profiles
7.1. BMC Medical Co., Ltd
7.1.1. Business overview
7.1.2. Financial performance
7.1.3. Product portfolio
7.1.4. Recent strategic moves & developments
7.1.5. SWOT analysis
7.2. Becton Dickinson (CareFusion Corporation)
7.2.1. Business overview
7.2.2. Financial performance
7.2.3. Product portfolio
7.2.4. Recent strategic moves & developments
7.2.5. SWOT analysis
7.3. Braebon Medical Corporation
7.3.1. Business overview
7.3.2. Financial performance
7.3.3. Product portfolio
7.3.4. Recent strategic moves & developments
7.3.5. SWOT analysis
7.4. Cadwell Laboratories Inc.
7.4.1. Business overview
7.4.2. Financial performance
7.4.3. Product portfolio
7.4.4. Recent strategic moves & developments
7.4.5. SWOT analysis
7.5. Compumedics Limited
7.5.1. Business overview
7.5.2. Financial performance
7.5.3. Product portfolio
7.5.4. Recent strategic moves & developments
7.5.5. SWOT analysis
7.6. Curative Medical Inc,
7.6.1. Business overview
7.6.2. Financial performance
7.6.3. Product portfolio
7.6.4. Recent strategic moves & developments
7.6.5. SWOT analysis
7.7. Fisher & Paykel Healthcare
7.7.1. Business overview
7.7.2. Financial performance
7.7.3. Product portfolio
7.7.4. Recent strategic moves & developments
7.7.5. SWOT analysis
7.8. GE Healthcare
7.8.1. Business overview
7.8.2. Financial performance
7.8.3. Product portfolio
7.8.4. Recent strategic moves & developments
7.8.5. SWOT analysis
7.9. ImThera Medical, Inc.
7.9.1. Business overview
7.9.2. Financial performance
7.9.3. Product portfolio
7.9.4. Recent strategic moves & developments
7.9.5. SWOT analysis
7.10. Invacare Corporation
7.10.1. Business overview
7.10.2. Financial performance
7.10.3. Product portfolio
7.10.4. Recent strategic moves & developments
7.10.5. SWOT analysis
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
